United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0363-0177_da638473-feb5-ccf1-e053-2a95a90a80d3
- Product NDC
- 0363-0177
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- Naproxen Sodium
- Labeler
- WALGREEN COMPANY
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190802
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (0363-0177-11) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 0363-0177-11
- 1 BOTTLE, PLASTIC in 1 CARTON (0363-0177-15) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 0363-0177-15
- 1 BOTTLE, PLASTIC in 1 CARTON (0363-0177-16) / 50 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 0363-0177-16
- 1 BOTTLE, PLASTIC in 1 CARTON (0363-0177-22) / 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 0363-0177-22
- 180 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0363-0177-25) · 0363-0177-25
- 1 BOTTLE, PLASTIC in 1 CARTON (0363-0177-78) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 0363-0177-78
- 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0363-0177-99) · 0363-0177-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →